Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Secukinumab in the treatment of moderate to severe hidradenitis suppurativa: Results of an open-label trial.
Casseres RG, Prussick L, Zancanaro P, Rothstein B, Joshipura D, Saraiya A, Turkowski Y, Au SC, Alomran A, Abdat R, Abudu M, Kachuk C, Dumont N, Gottlieb AB, Rosmarin D. Casseres RG, et al. Among authors: zancanaro p. J Am Acad Dermatol. 2020 Jun;82(6):1524-1526. doi: 10.1016/j.jaad.2020.02.005. Epub 2020 Feb 7. J Am Acad Dermatol. 2020. PMID: 32044410 Clinical Trial. No abstract available.
Open-label, investigator-initiated, single-site exploratory trial evaluating secukinumab, an anti-interleukin-17A monoclonal antibody, for patients with moderate-to-severe hidradenitis suppurativa.
Prussick L, Rothstein B, Joshipura D, Saraiya A, Turkowski Y, Abdat R, Alomran A, Zancanaro P, Kachuk C, Dumont N, Gottlieb AB, Rosmarin D. Prussick L, et al. Among authors: zancanaro p. Br J Dermatol. 2019 Sep;181(3):609-611. doi: 10.1111/bjd.17822. Epub 2019 May 12. Br J Dermatol. 2019. PMID: 30801662 Clinical Trial. No abstract available.
A Retrospective Review of Dupilumab for Hand Dermatitis.
Lee N, Chipalkatti N, Zancanaro P, Kachuk C, Dumont N, Rosmarin D. Lee N, et al. Among authors: zancanaro p. Dermatology. 2019;235(3):187-188. doi: 10.1159/000496481. Epub 2019 Feb 6. Dermatology. 2019. PMID: 30726838 Free article. No abstract available.
Dupilumab as a Treatment for Allergic Contact Dermatitis.
Chipalkatti N, Lee N, Zancanaro P, Dumont N, Donovan C, Rosmarin D. Chipalkatti N, et al. Among authors: zancanaro p. Dermatitis. 2018 Nov/Dec;29(6):347-348. doi: 10.1097/DER.0000000000000414. Dermatitis. 2018. PMID: 30346326 No abstract available.
Response to ustekinumab in three pediatric patients with alopecia areata.
Aleisa A, Lim Y, Gordon S, Her MJ, Zancanaro P, Abudu M, Deverapalli SC, Madani A, Rosmarin D. Aleisa A, et al. Among authors: zancanaro p. Pediatr Dermatol. 2019 Jan;36(1):e44-e45. doi: 10.1111/pde.13699. Epub 2018 Oct 18. Pediatr Dermatol. 2019. PMID: 30338558
24 results